These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34926894)

  • 1.
    Prajapati R; Seong SH; Paudel P; Park SE; Jung HA; Choi JS
    ACS Omega; 2021 Dec; 6(49):33443-33453. PubMed ID: 34926894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Diels-Alder Type Adducts from
    Paudel P; Park SE; Seong SH; Jung HA; Choi JS
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing Multi-Target Action of Phlorotannins as New Monoamine Oxidase Inhibitors and Dopaminergic Receptor Modulators with the Potential for Treatment of Neuronal Disorders.
    Seong SH; Paudel P; Choi JW; Ahn DH; Nam TJ; Jung HA; Choi JS
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31238535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing fucoxanthin as a selective dopamine D
    Paudel P; Seong SH; Jung HA; Choi JS
    Chem Biol Interact; 2019 Sep; 310():108757. PubMed ID: 31323226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist.
    Sánchez-Soto M; Bonifazi A; Cai NS; Ellenberger MP; Newman AH; Ferré S; Yano H
    Mol Pharmacol; 2016 Apr; 89(4):457-66. PubMed ID: 26843180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Human Monoamine Oxidase Inhibition and Human Dopamine D
    Paudel P; Choi JS; Prajapati R; Seong SH; Park SE; Kang WC; Ryu JH; Jung HA
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin, a Potent Human Monoamine Oxidase-A Inhibitor and Dopamine D
    Park SE; Paudel P; Wagle A; Seong SH; Kim HR; Fauzi FM; Jung HA; Choi JS
    J Agric Food Chem; 2020 Sep; 68(39):10719-10729. PubMed ID: 32869630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D
    Shioda N; Imai Y; Yabuki Y; Sugimoto W; Yamaguchi K; Wang Y; Hikida T; Sasaoka T; Mieda M; Fukunaga K
    J Neurosci; 2019 Sep; 39(38):7551-7563. PubMed ID: 31371425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of human D1 and D5 dopaminergic G protein-coupled receptors: lessons from mutagenesis of a conserved serine residue in the cytosolic end of transmembrane region 6.
    Plouffe B; Tiberi M
    Methods Mol Biol; 2013; 964():141-80. PubMed ID: 23296783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.
    Zhao W; Huang Y; Liu Z; Cao BB; Peng YP; Qiu YH
    PLoS One; 2013; 8(6):e65860. PubMed ID: 23799052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.
    Wang X; Li F; Jose PA; Ecelbarger CM
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1164-70. PubMed ID: 20810614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing GPCR Targets of hMAO Active Anthraquinones from
    Paudel P; Seong SH; Fauzi FM; Bender A; Jung HA; Choi JS
    ACS Omega; 2020 Apr; 5(13):7705-7715. PubMed ID: 32280914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-Dependent Dopamine Potency at D
    Ågren R; Sahlholm K
    Front Pharmacol; 2020; 11():581151. PubMed ID: 33117177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
    Lanza K; Chemakin K; Lefkowitz S; Saito C; Chambers N; Bishop C
    Psychopharmacology (Berl); 2020 Jan; 237(1):155-165. PubMed ID: 31435690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors.
    Cho DI; Beom S; Van Tol HH; Caron MG; Kim KM
    Biochem Biophys Res Commun; 2006 Nov; 350(3):634-40. PubMed ID: 17022946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the dopamine D3 receptor: an overview of drug design strategies.
    Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V
    Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity Induced by Sophora flavescens and Hepatic Accumulation of Kurarinone, a Major Hepatotoxic Constituent of Sophora flavescens in Rats.
    Jiang P; Zhang X; Huang Y; Cheng N; Ma Y
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29068394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
    Kumar U; Patel SC
    Brain Res; 2007 Feb; 1131(1):187-96. PubMed ID: 17182012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease.
    Fuxe K; Guidolin D; Agnati LF; Borroto-Escuela DO
    Expert Opin Ther Targets; 2015 Mar; 19(3):377-98. PubMed ID: 25486101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats.
    Dupre KB; Ostock CY; George JA; Eskow Jaunarajs KL; Hueston CM; Bishop C
    ACS Chem Neurosci; 2013 May; 4(5):747-60. PubMed ID: 23496922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.